Meng-Meng Tian1, Yu Sun, Zhong-Wu Li, Ying Wu, Ai-Lian Zhao, Ji-You Li. 1. Key Laboratory of Carcinogenesis and Translational Research, Department of Pathology, Peking University School of Oncology, Beijing Cancer Hospital and Institute, Beijing 100142, China.
Abstract
AIM: To investigate the association between single nucleotide polymorphisms (SNPs) in intercellular adhesion molecule-1 (ICAM-1) and the risk, biological behavior and prognosis of gastric cancer (GC) in Chinese population. METHODS: The study group consisted of 332 GC patients and 380 healthy controls. Genotyping was performed using polymerase chain reaction and the results were confirmed by sequencing. The association of ICAM-1 K469E polymorphisms and the risk of GC were studied, and the correlation of ICAM-1 K469E polymorphisms with the clinicopathological parameters and prognosis of the patients with complete clinical and follow-up data was analyzed. RESULTS: Carriers of AA genotype had a significantly increased risk of GC compared with carriers of AG and GG genotypes [odds ratios: 1.36; 95% confidence interval (CI): 1.01-1.84; P = 0.041]. GC patients with AA genotype were more prone to distant metastasis than those carrying AG and GG genotypes (18.9% vs 7.0%, respectively; P = 0.002). In addition, patients at stage IV had significantly more carriers of AA genotype than those of AG and GG genotype (27.4% vs 16.9%, respectively; P = 0.046). Follow-up study showed that the overall cumulative survival rate was 23.7% in AA genotype group and 42.9% in AG and GG genotypes group. In univariate analysis, AA genotype was correlated with the overall cumulative survival (P = 0.034). But in multivariate analysis, ICAM-1 polymorphism was not an independent prognostic factor for the overall survival (relative risk, 1.145; 95% CI: 0.851-1.540; P = 0.370). CONCLUSION: Polymorphisms of ICAM-1 K469E can be a useful biomarker for identifying individuals with higher risk of GC, predicting disease progression, and guiding individualized treatment.
AIM: To investigate the association between single nucleotide polymorphisms (SNPs) in intercellular adhesion molecule-1 (ICAM-1) and the risk, biological behavior and prognosis of gastric cancer (GC) in Chinese population. METHODS: The study group consisted of 332 GC patients and 380 healthy controls. Genotyping was performed using polymerase chain reaction and the results were confirmed by sequencing. The association of ICAM-1K469E polymorphisms and the risk of GC were studied, and the correlation of ICAM-1K469E polymorphisms with the clinicopathological parameters and prognosis of the patients with complete clinical and follow-up data was analyzed. RESULTS: Carriers of AA genotype had a significantly increased risk of GC compared with carriers of AG and GG genotypes [odds ratios: 1.36; 95% confidence interval (CI): 1.01-1.84; P = 0.041]. GC patients with AA genotype were more prone to distant metastasis than those carrying AG and GG genotypes (18.9% vs 7.0%, respectively; P = 0.002). In addition, patients at stage IV had significantly more carriers of AA genotype than those of AG and GG genotype (27.4% vs 16.9%, respectively; P = 0.046). Follow-up study showed that the overall cumulative survival rate was 23.7% in AA genotype group and 42.9% in AG and GG genotypes group. In univariate analysis, AA genotype was correlated with the overall cumulative survival (P = 0.034). But in multivariate analysis, ICAM-1 polymorphism was not an independent prognostic factor for the overall survival (relative risk, 1.145; 95% CI: 0.851-1.540; P = 0.370). CONCLUSION: Polymorphisms of ICAM-1K469E can be a useful biomarker for identifying individuals with higher risk of GC, predicting disease progression, and guiding individualized treatment.
Authors: Caridad Rosette; Richard B Roth; Paul Oeth; Andreas Braun; Stefan Kammerer; Jonas Ekblom; Mikhail F Denissenko Journal: Carcinogenesis Date: 2005-03-17 Impact factor: 4.944
Authors: Stefan Kammerer; Richard B Roth; Richard Reneland; George Marnellos; Carolyn R Hoyal; Nathan J Markward; Florian Ebner; Marion Kiechle; Ulrike Schwarz-Boeger; Lyn R Griffiths; Christian Ulbrich; Korbinian Chrobok; Gerhard Forster; Georg M Praetorius; Peter Meyer; Joachim Rehbock; Charles R Cantor; Matthew R Nelson; Andreas Braun Journal: Cancer Res Date: 2004-12-15 Impact factor: 12.701
Authors: Krzysztof Ksiazek; Justyna Mikuła-Pietrasik; Rusan Catar; Grzegorz Dworacki; Marek Winckiewicz; Magdalena Frydrychowicz; Duska Dragun; Ryszard Staniszewski; Achim Jörres; Janusz Witowski Journal: Int J Cancer Date: 2010-07-15 Impact factor: 7.396
Authors: Qing-lei Wang; Bing-hui Li; Bin Liu; Ya-bin Liu; Yue-Ping Liu; Sui-Bing Miao; Yi Han; Jin-Kun Wen; Mei Han Journal: J Exp Clin Cancer Res Date: 2009-10-13
Authors: Ye Wang; Liuqun Jia; Yongchun Shen; Shujin Guo; Chun Wan; Ting Yang; Jing An; Lei Chen; Tao Wang; Fuqiang Wen Journal: Int J Clin Exp Med Date: 2014-01-15
Authors: Ravindran Ankathil; Mohd Aminudin Mustapha; Ahmad Aizat Abdul Aziz; Siti Nurfatimah Mohd Shahpudin; Andee Dzulkarnaen Zakaria; Muhammad Radzi Abu Hassan; Kamarul Imran Musa Journal: Asian Pac J Cancer Prev Date: 2019-06-01